Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

IL-12 offers new approach to BMT in leukemia patients

Jan. 20, 1998

MedImmune and SmithKline Beecham finalize vaccine agreement

Jan. 20, 1998

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

Jan. 19, 1998

Daclizumab efficacy demonstrated in transplant recipients

Jan. 16, 1998

Novel polyspecific antibody-agent conjugates from Immunomedics

Jan. 16, 1998

Dysentery vaccine technology available for licensing from NIH

Jan. 15, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novel thalidomide prodrugs reported in patent literature

Jan. 12, 1998

ABX-CBL evaluated in phase II GVHD trial

Jan. 7, 1998

New immunosuppressants in the pipeline at Merck & Co.

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...